MAPT and Alzheimer disease: An increase in Ca2+ levels is functionally related to most pathological features and pathogenic factors of AD, such as presenilin and APP mutations, APOE4 expression, CALHM1 mutation, Aβ plaque formation, tau hyperphosphorylation, apoptosis and synaptic dysfunction [100].